Jill Stefanelli
Directeur/Bestuurslid bij NAVIDEA BIOPHARMACEUTICALS, INC.
Vermogen: - $ op 31-05-2024
Profiel
Jill Bieker Stefanelli is an Independent Director at Navidea Biopharmaceuticals, Inc. since 2023.
Previously, she was the President, Director & Chief Business Officer at Paige.
Ai, Inc. She obtained her undergraduate, graduate, and doctorate degrees from Kansas State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
16-11-2023 | 941 667 ( 0.94% ) | - $ | 31-05-2024 |
Actieve functies van Jill Stefanelli
Bedrijven | Functie | Begin |
---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-06-2023 |
Eerdere bekende functies van Jill Stefanelli
Bedrijven | Functie | Einde |
---|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | President | - |
Opleiding van Jill Stefanelli
Kansas State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |